SEC Form 4 · accession 0001855616-26-000024
NeuroPace Inc · NPCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha Morrell
Officer — CHIEF MEDICAL OFFICER
Period of report
Sep 24, 2026
Accepted (ET)
Sep 25, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001528287
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 24, 2026 | F | 335 | $13.97 | D | 51,357 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.